Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Comp. Effectiveness Promises Better, Cheaper Health Care But Critics Link It To Rationing
"Federal health agencies, seeking to hand out stimulus funds to research the effectiveness of various medical treatments, said they will include projects that look in part at the cost of drugs and other treatments. The approach -- which was unveiled in a report to Congress this week by the Agency for Healthcare Research and Quality and the National Institutes of Health, both agencies under the Department of Health and Human Services -- could provide more fodder to conservatives worried that the government might use the results of such studies to limit health care to consumers," the Wall Street Journal reports.

Arete Therapeutics Presents Positive Clinical And Preclinical Data For AR9281
Arete Therapeutics Inc. announced the presentation of three posters that validate the mechanistic activity and therapeutic potential of the company"s lead drug candidate, AR9281, an orally-administered soluble epoxide hydrolase (sEH) inhibitor that is in a Phase II clinical program for the treatment of type 2 diabetes. sEH is an enzyme involved in the metabolism of arachidonic acid, a key signaling molecule implicated in diabetes, hypertension and inflammatory disorders.
News of the day
Exposure To Bisphenol A In Pregnant Mice Permanently Changes DNA Of Offspring
Exposure during pregnancy to the chemical bisphenol A, or BPA, found in many common plastic household items, is known to cause a fertility defect in the mother"s offspring in animal studies, and now researchers have found how the defect occurs. The results of the new study will be presented Saturday at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
Sexual Health

New Strategies For Cell Therapy To Regenerate Damaged Heart

Research undertaken at the Center for Applied Medical Research (CIMA) and the University Hospital of Navarra has shown that, in animal models, stem cells derived from bone marrow and adipose tissue enhance heart function after a cardiac attack. In concrete, bone marrow cells act on the damaged tissue, while fatty cells have the ability to transform themselves into both blood vessels and cardiac cells. The results obtained with rats are maintained over a long time period, explained biochemist Mr Manuel Mazo, principal researcher. When a person suffers a heart attack, the artery feeding the heart is obstructed The affected tissue dies and the scar tissue left des not contract. It is a serious problem as cardiac muscle does not regenerate, with grave consequences for the functional capacity of the heart, a situation which can trigger heart failure, explained the scientist. Mortality for cardiovascular diseases Myocardial arrest is a pathology which has one of the highest rates worldwide. In fact, the overall number of cardiovascular illnesses represents 50% of deaths in Europe, according to the world Health Organisation. For a decade now they have been investigating new strategies of genic therapy and cell therapy that enable the repopulation of the scar tissue in the heart in order to regenerate it. In the opinion of Dr. Manuel Mazo, the data obtained at CIMA suggest that this procedure has a highly important potential in its clinical application. This is why the effects which are being achieved have to be improved in both animal models as well as in other, multicentre clinical trials. In this way, the future of the research is focused on combining cell therapy and bioengineering, in such a way that genetically modified cells surviving from adverse conditions in the heart are available. Elhuyar Fundazioa


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009